Augustin Ferrant
Overview
Explore the profile of Augustin Ferrant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Marty F, Ljungman P, Papanicolaou G, Winston D, Chemaly R, Strasfeld L, et al.
Lancet Infect Dis
. 2011 Mar;
11(4):284-92.
PMID: 21414843
Background: Available drugs against cytomegalovirus have adverse effects that compromise their prophylactic use in recipients of allogeneic stem-cell transplants. We assessed the safety, tolerability, and antiviral activity of oral maribavir...
12.
Lowenberg B, Pabst T, Vellenga E, van Putten W, Schouten H, Graux C, et al.
N Engl J Med
. 2011 Mar;
364(11):1027-36.
PMID: 21410371
Background: Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic but...
13.
Kyriakou C, Canals C, Cornelissen J, Socie G, Willemze R, Ifrah N, et al.
J Clin Oncol
. 2010 Oct;
28(33):4926-34.
PMID: 20956626
Purpose: Allogeneic stem-cell transplantation (alloSCT) is a curative therapeutic option for patients with low-grade lymphoid malignancies. Information regarding alloSCT in Waldenström macroglobulinemia (WM) is limited. This study presents the long-term...
14.
Duarte R, Canals C, Onida F, Gabriel I, Arranz R, Arcese W, et al.
J Clin Oncol
. 2010 Aug;
28(29):4492-9.
PMID: 20697072
Purpose: To analyze the outcome of allogeneic transplantation for mycosis fungoides and Sézary syndrome (MF/SS) in terms of nonrelapse mortality (NRM), relapse/progression (REL), progression-free survival (PFS), and overall survival (OS)...
15.
Lugthart S, Groschel S, Beverloo H, Kayser S, Valk P, van Zelderen-Bhola S, et al.
J Clin Oncol
. 2010 Jul;
28(24):3890-8.
PMID: 20660833
Purpose: Acute myeloid leukemia (AML) with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) [inv(3)/t(3;3)] is recognized as a distinctive entity in the WHO classification. Risk assignment and clinical and genetic characterization of AML with chromosome 3q...
16.
Paesmans M, Klastersky J, Maertens J, Georgala A, Muanza F, Aoun M, et al.
Support Care Cancer
. 2010 Jul;
19(7):1001-8.
PMID: 20596732
Background: Febrile neutropenic cancer patients represent a heterogeneous population with a limited proportion at risk of serious medical complications. The Multinational Association for Supportive Care in Cancer (MASCC) score has...
17.
de Witte T, Hagemeijer A, Suciu S, Belhabri A, Delforge M, Kobbe G, et al.
Haematologica
. 2010 May;
95(10):1754-61.
PMID: 20494931
Background: Allogeneic stem cell transplantation is usually considered the only curative treatment option for patients with advanced or transformed myelodysplastic syndromes in complete remission, but post-remission chemotherapy and autologous stem...
18.
Girardot M, Pecquet C, Boukour S, Knoops L, Ferrant A, Vainchenker W, et al.
Blood
. 2010 May;
116(3):437-45.
PMID: 20445018
BCR-ABL negative myeloproliferative neoplasms (MPNs; polycythemia vera, essential thrombocythemia, primary myelofibrosis) are malignant diseases arising from a multipotent hematopoietic progenitor, frequently altered by JAK2 V617F or other JAK/STAT activating mutations....
19.
Lowenberg B, Beck J, Graux C, van Putten W, Schouten H, Verdonck L, et al.
Blood
. 2010 Jan;
115(13):2586-91.
PMID: 20103782
In older patients with acute myeloid leukemia (AML), the prevention of relapse has remained one of the major therapeutic challenges, with more than 75% relapses after complete remission. The anti-CD33...
20.
Ades L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S, et al.
Blood
. 2009 Dec;
115(9):1690-6.
PMID: 20018913
Acute promyelocytic leukemia (APL) is highly curable with the combination of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy (CT), but very long-term results of this treatment, when CT should be...